Cytodyn Inc (CYDY)

[BlackDoggie]

Per the recent webcast, protocol for TNBC is that the first 18 patients will do dose escalation through 350, 525, and 700. The remaining 30 will be on 700. They made a point of saying that they would be taking CTC readings from the lower dose cohorts as well, and wouldn’t hesitate to apply for BTD based on strong surrogate endpoint results in the early cohorts.

Assuming any efficacy and given the safety data we have from HIV, the cancer trials have all the makings of something the FDA would stop and grant AA on the condition that the trials are finished, etc. Not to count chickens, that’s just the facts as I see them and as they continue to be revealed.